Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events

INTRODUCTION: Immune checkpoint inhibitors (ICIs) are effective in treating several cancers; however, acute kidney injury (AKI) can occur as part as an immune-related adverse event (iRAE). Biomarkers at the time of AKI diagnosis may help determine whether they are ICI- related and guide therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Isik, Busra, Alexander, Mariam P., Manohar, Sandhya, Vaughan, Lisa, Kottschade, Lisa, Markovic, Svetomir, Lieske, John, Kukla, Aleksandra, Leung, Nelson, Herrmann, Sandra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071627/
https://www.ncbi.nlm.nih.gov/pubmed/33912752
http://dx.doi.org/10.1016/j.ekir.2021.01.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071627/
https://www.ncbi.nlm.nih.gov/pubmed/33912752
http://dx.doi.org/10.1016/j.ekir.2021.01.013

Ejemplares similares